DOCSLIB.ORG

Procter & Gamble Teams with Teva in OTC Market

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Procter & Gamble Teams with Teva in OTC Market OTC31-03-11p1&24FIN.qxd 31/3/11 07:09 Page 1 31 March 2011 COMPANY NEWS 3 Procter & Gamble teams Walgreens to acquire 3 drugstore.com Novartis UK plans 3 to move Consumer with Teva in OTC market OTC turnover disappoints 4 at Celesio Germany’s Bionorica 6 rocter & Gamble has signed a ‘master ledge, plus a network of mass-retail partners. pushes into the UK Pagreement’with Teva Pharmaceutical Yanai’s counterpart at Procter & Gamble, Galenica’s Vifor OTC unit 7 Industries to create a consumer healthcare Bob McDonald, pointed out that Teva’s exten- reports gains partnership, including a joint venture that sive portfolio in categories such as allergy,gas- NBTY reports loss 8 will bring together each firm’s OTC port- trointestinal and respiratory would provide a in wake of takeover folio. However, Procter & Gamble will re- pipeline of potential prescription-to-non-pre- Linola and Vagisan lift 9 tain full control of its North American OTC scription switches that could either become new sales at Dr Wolff operations. lines or extensions to Procter & Gamble brands Alliance Pharma poised 10 The joint venture – in which Procter & such as Metamucil, Pepto-Bismol and Vicks. to acquire Anbesol brand Gamble will hold 51% and Teva 49% – will Details of the collaboration are currently be- SEEK to auction 10 combine the two companies’ OTC operations ing finalised. Subject to regulatory approval, the cough-drug rights in all markets outside of North America and two firms expect to close the deal this autumn. will have annual sales of more than US$1 bil- The chief executive officer of the joint ven- GENERAL NEWS 11 lion (C700 million) on formation. ture will be Procter & Gamble’s Briain de Buit- Teva believes it could become a US$4 bil- leir. The joint venture’s chief financial officer Germany’s BfArM reveals 11 plan to compare triptans lion business within a few years. The Israeli will also be recruited from Procter & Gamble, firm will assume global manufacturing respon- but the chief operating officer role will be filled EFSA has plan to 11 be more like EMA sibility for both the joint venture and Procter by a Teva employee. & Gamble’s existing North American business. Expanding on the rationale behind the tie- MARKETING NEWS 13 Shlomo Yanai, Teva’s president and chief up, Yanai said the partnership enabled “two executive officer,insisted the partnership had global leaders” not only to combine their busi- Ratiopharm returns to 13 the “potential to reshape the entire global OTC nesses and research and development portfolios, twin-based advertising market”. Teva would bring the world’s largest but also a set of “complementary capabilities” Manx takes on Cyklo-F 14 portfolio of medicines as well as extensive ex- he believed were “unmatchable in the health- with Femstrual launch pertise in developing, registering and making care industry”. Omega claims Prevalin 15 those drugs in more than 60 markets, he said. Yanai noted the joint venture’s annual sales protects from hayfever Procter & Gamble,on the other hand, would of US$1 billion would include leading market Novartis takes Otriven 16 contribute brand-building and marketing know- ■ Continued on page 11 into the hayfever arena FEATURES 18 French market falters 18 Hornby quits as Alliance Boots’ chief despite ‘free-access’ A look at the 2010 market trends ndy Hornby has stepped down as group sion “in amicable mutual agreement” with the German firms foresee 20 Achief executive of Alliance Boots. firm’s supervisory board. He has been Cele- a price fall Hornby said that he had decided to “take sio’s chief executive officer for 12 years. Findings of a survey of consumers, a few months break” following an “intense last Alliance Boots recruited Hornby two years pharmacists and industry five years as chief executive officer of two maj- ago from UK banking group HBOS, where he REGULARS or companies”. had led the retail division before becoming The news comes soon after rival pan-Euro- chief executive officer. He had previously work- Events – Our regular listing 17 pean retailer and wholesaler Celesio announc- ed at the supermarket chain Asda (OTC bul- People – Celesio recruits Borchert 22 ed that its chairman and chief executive offi- letin, 19 June 2009, page 1). from Douglas retail chain cer,Fritz Oesterle, would retire earlier than The company said it would “undertake an People – Germany’s BAH names 23 expected on 30 June 2011 (OTC bulletin,17 internal and external search for a successor to new replacement for Seidscheck March 2011, page 19). lead the next phase of its international growth Celesio said Oesterle had reached the deci- and development”. OTC31-03-11p2-3FIN.qxd 30/3/11 12:20 Page 3 COMPANY NEWS OTC WaMergers & Acquisitionslgreens to acquire drugstore.com S drugstore giant Walgreens is set to ac- more than three million ‘savvy’, loyal online Uquire online retailer drugstore.com in a customers,”Wasson pointed out, “and will allow deal with a total enterprise value of approxi- us to move even closer to our existing custom- mately US$409 million (C322 million). ers through relationships with new vendors and Greg Wasson, Walgreen’s president and chief partners, adding approximately 60,000 products executive officer,said the deal “significantly” to our already strong online offering.” Drugstore.com was ranked the eighth-largest accelerated the firm’s online strategy. Moreover, With sales of more than US$456 million in “e-tailer” in the US by Internet Retailer magazine it complemented the activities of Walgreens’ 2010, drugstore.com was ranked as the eighth- 7,689-strong drugstore chain, and was another largest “e-tailer” in the US by Internet Retailer beauty and skincare websites and add the firm’s step towards the company’s goal of becoming magazine, Walgreens pointed out. “talented team” to Walgreen’s “strong and grow- the “most convenient multi-channel retailer of As a result of the deal, Walgreens will gain ing” e-commerce organisation. health and daily living needs in America”. the drugstore.com website, along with other Drugstore.com stockholders will get US$3.80 “This acquisition offers a unique opportunity websites operated by the firm including Beauty. per share from the deal. Subject to approval by that will provide us with immediate access to com, SkinStore.com and VisionDirect.com. drugstore.com’s stockholders and regulatory Walgreens said it would maintain separate authorities, the deal is expected to close by the branding of drugstore.com’s websites. end of June 2011. OTC bulletin Sona Chawla, Walgreen’s president of e- Meanwhile, Walgreens is set to sell its phar- commerce, said the deal enabled the company macy-benefit management business to Catalyst 31 March 2011 Number 359 to expand its product offering, acquire new cap- Health Solutions in a cash transaction worth abilities through drugstore.com’s well-known US$525 million, subject to certain adjustments. Editor & Publisher: Deborah Wilkes OTC Associate Editors: Aidan Fry Mike Rice Business Strategy Business Strategy/Annual Results Business Editor: Matt Stewart Assistant Editors: Jenna Lawrence Novartis UK plans Germany’s Hevert David Wallace Advertising Controller: Debi Minal to move Consumer looks towards east Marketing Manager: Val Davis ovartis is set to relocate some of its Con- erman homoeopathic specialist Hevert Editorial, Subscription and Advertising Nsumer Health operations in the UK, after G Arzneimittel intends to expand eastwards enquiries should be addressed to: OTC bulletin, OTC Publications Ltd, 54 Creynolds Lane, Solihull, drawing up proposals to reduce activities at as it aims to continue its recent growth trend. West Midlands B90 4ER, UK. its site in Horsham, West Sussex. “We have high hopes of entering Russia Tel: +44 1564 777550. Fax: +44 1564 777524. A spokesperson for Novartis told OTC bul- and selected Commonwealth of Independent E-mail: [email protected]. letin that the proposal envisaged moving the States (CIS) markets with two of our homoeo- Subscriptions Consumer Health operations carried out at Hor- pathic products,”stated the family-owned firm’s Annual subscriptions to OTC bulletin in Europe are £625.00 for single copies and £355.00 for additional copies to the same ad- sham to Frimley in Surrey, where the comp- managing director,Mathias Hevert. dress, including delivery. Subscriptions to addresses outside Eur- any’s Animal Health business and Sandoz gen- To cope with the expected increase in de- ope are subject to an additional charge of £30.00 to cover postage. Subscription enquiries in Korea should be directed to Pharma erics unit are already based. mand, Hevert will this year expand production Koreana Ltd, 14th Floor,KTB Network Building, 826-14 Yeoksam- About 80 Novartis Consumer Health staff capacity at its headquarters in Nussbaum, near dong, Kangnam-gu, Seoul 135-080, Korea (Tel: +82 2 554 9591; Fax: +82 2 563 8289; E-mail: [email protected]). currently work at Horsham, the spokesperson Frankfurt. “While other companies rely on con- Advertising noted, covering a variety of functions, the largest tract manufacturing, we are building strongly Advertising rates and data are available on request from the ad- of which were sales and marketing, research on our identity as a natural remedies producer,” dress above or at www.otc-bulletin.com. About OTC bulletin and development and global manufacturing commented Hevert. OTC bulletin is published 20 times a year by OTC Publications and supply. In its domestic market, the German com- Limited: twice monthly in February,March, April, May,June, Sep- tember,October and November; and monthly in December,Jan- The spokesperson would not comment on pany has just started a television campaign for uary,July and August. A subscription to OTC bulletin includes whether the proposed move would lead to any its homoeopathic anxiety remedy,Calmvalera the weekly electronic newsflash, news@OTCbulletin,which is published around 45 times a year.
Load more

Recommended publications
  • Inside This Issue
    1 December 23, 2014 – Issue 122 INSIDE THIS ISSUE China Green Food Expo to be Held in Nanchang China Green Food Expo to be The seventh China Green Food Expo is to be held in Nanchang, Held in Nanchang Jiangxi province. Companies from more than 30 provinces will attend the Expo with thousands of attendees to the event. Jan-Oct China Health Insurance The event is co-held by Ministry of Commerce and Jiangxi local Premium Exceeded CNY 130bn government. CFDA: Cosmeceuticals Should not The Expo tends to promote the economic rise of middle area of Promote Itself as Medicines the country and the opening-up of Jiangxi province. The event will include the food expo and a cooperation seminar joined by Shi Jiazhuang to Crack Down on state-run companies with local food providers and vendors. Illegal Health Food and Cosmetics The Expo mainly features low-carbon industry and green food. It will cover six indoor exhibiting rooms with food companies from Amorepacific Taps Surging more than 30 provinces. Overseas vendors from Australia, Demand for Midrange Beauty America, Russia and Thailand will also bring food to the local Products consumers who will attend the expo. （Source: Food Safety Daily) China Nepstar: A Bitter Pill For Investors Jan-Oct China Health Insurance Premium Exceeded CNY 130bn Herbal Berberine Boosts Brown Fat Activity Premium income of health insurance exceeded CNY 136.656 billion in the first 10 months of this year, growing 45.25% year on year, according to China Insurance Regulatory Commission. Premium income of life insurance companies grew 19.36% year on year.
    [Show full text]
  • Alliance Boots Preliminary Results Announcement for the Year Ended 31 March 2010
    Press release 17 May 2010 Alliance Boots Preliminary results announcement for the year ended 31 March 2010 “A strong performance delivering double digit growth in trading profit” Highlights: Group • Revenue, including share of associates and joint ventures, up 9.6% to £22.5 billion • EBITDA, including share of associates and joint ventures, up 9.2% to £1,360 million • Trading profit, including share of associates and joint ventures, up 12.7% to £1,074 million • Underlying profit (after tax) more than doubled to £602 million • Cash generated from operations £1,130 million • Net borrowings reduced by £645 million Health & Beauty Division • Revenue up 5.2% – up 4.5% in constant currency • Trading profit up 8.5% • Boots UK - Like for like retail revenue up 3.0% - ‘your local Boots pharmacy’ roll-out completed - No7 Protect & Perfect Intense Beauty Serum launched • Boots Opticians merged with Dollond & Aitchison Pharmaceutical Wholesale Division • Revenue up 10.3% – up 5.6% in constant currency • Trading profit up 17.2% • Business improvement programme largely completed • Further selective deals with manufacturers Stefano Pessina, Executive Chairman, commented: “Since taking the company private, this is our third consecutive year of double digit trading profit growth. Having invested more than £1 billion over the period, we are confident that we are building a platform for sustained long term growth. “Our strong financial position will enable us to continue to grow both organically and through acquisitions. We are increasingly establishing strategic partnerships with other leading businesses to accelerate our development, both in the UK and other markets.” Andy Hornby, Group Chief Executive, said: “Alliance Boots performed strongly in 2009/10, delivering a double digit trading profit growth, combined with a robust cash flow.
    [Show full text]
  • China Digest
    China Digest China by numbers Round-up of business news, current issues, • 13,548 meters - combined height of and M&A analysis skyscrapers built in China in 2014 • 3 – number of world’s 10 tallest buildings Q1 2015 built in Wuxi city in 2014 • 7% - share of global freshwater in China In the news … (vs. 20% of world population) • 7 - of China’s ten most polluted cities are Subsidies cut for non-electric vehicles [Auto] in Hebei province The Ministry of Finance reports it is to reduce subsidies for traditional vehicles in • 30,000 - number of TV drama episodes an effort to boost the country’s renewable energy vehicle market. A program to build made in China annually charging infrastructure will also be accelerated. Aside from helping reduce urban pollution levels, the subsidy cut could encourage take-up of electric and hybrid • 14 - number of countries bordering China vehicles and boost domestic manufacturers such as BYD. (Caixin) • 648 million - China's online population • 280 million - number of people in China Growth of China O&G consumption to slow in 2015 [Energy] without safe drinking water China’s oil & gas consumption is expected to see slower growth this year, with falling • $1,831 - President Xi Jinping’s monthly global crude prices providing an opportunity for more energy sector reforms, salary according to the Economic and Technology Research Institute of the country’s • $1.2billion - annual US drug exports to largest O&G producer, China National Petroleum Corp. Chinese oil demand will China grow 3% year-on-year to 534 million metric tons in 2015, compared to growth of • $119.6 billion - China's actual use of 3.3% (to 516 million tons) in 2014, it said.
    [Show full text]
  • Building an Ethical Small Group (Chapter 9 of Meeting the Ethical Challenges of Leadership) Craig E
    Digital Commons @ George Fox University Faculty Publications - School of Business School of Business 2018 Building an Ethical Small Group (Chapter 9 of Meeting the Ethical Challenges of Leadership) Craig E. Johnson George Fox University, [email protected] Follow this and additional works at: https://digitalcommons.georgefox.edu/gfsb Part of the Business Commons, and the Ethics and Political Philosophy Commons Recommended Citation Johnson, Craig E., "Building an Ethical Small Group (Chapter 9 of Meeting the Ethical Challenges of Leadership)" (2018). Faculty Publications - School of Business. 94. https://digitalcommons.georgefox.edu/gfsb/94 This Article is brought to you for free and open access by the School of Business at Digital Commons @ George Fox University. It has been accepted for inclusion in Faculty Publications - School of Business by an authorized administrator of Digital Commons @ George Fox University. For more information, please contact [email protected]. Building a11 Ethical Small Group Cooperation is the thorough conviction that nobody can get there unless everybody gets there. -AUTHOR VIRGINIA BURDEN TOWER Never underestimate a minority. -BRITISH PRIME MINISTER WINSTON CHURCHILL WHAT'S AHEAD This chapter examines ethical leadership in the small-group context. To help create groups that brighten rather than darken the lives of participants, leaders must foster individual ethical accountability among group members, ensure ethical group interac­ tion, avoid moral pitfalls, and establish ethical relationships with
    [Show full text]
  • Annual Report 2019.Pdf
    Annual Report 2019 Contents Introduction Overview The Restaurant Group operates Highlights and priorities 01 over 650 restaurants and pub Strategic report restaurants. Its principal trading brands Chairman’s statement 04 Business review 05 are Wagamama, Frankie & Benny’s, Financial review 10 Chiquito and Coast to Coast. The Group Corporate social responsibility 14 also operates Pub restaurants and a Concessions business which trades Governance Corporate Governance report 20 principally at UK airports. Board of Directors 30 Audit Committee report 32 Nomination Committee report 37 Directors’ remuneration report 41 Directors’ report 56 Senior Management Risk Committee 58 Directors’ responsibility statements 60 Our brands Financial statements Independent auditor’s report 61 Consolidated income statement 71 Consolidated balance sheet 72 Consolidated statement of changes in equity 73 Consolidated cash flow statement 74 Notes to the consolidated accounts 75 Company balance sheet 112 Statement of changes in equity 113 Notes to the Company accounts 114 Group financial record 120 Glossary 121 Shareholder information 122 Overview Highlights and priorities Operating highlights • Delivering the benefits of the Wagamama transaction – Market-leading like-for-like (LFL) sales performance of +8.5% report Strategic – Cost synergies ahead of plan, site conversion programme well progressed – US Joint Venture (JV) established after year-end to facilitate capital-light growth plan • Growing our Pubs and Concessions businesses – Concessions LFL sales growth
    [Show full text]
  • Fraser of Allander Institute Economic Commentary
    Fraser of Allander Institute Economic Commentary Vol 39 No. 2 In association with The Scottish economy Outlook and appraisal .................................................................... 3 Forecasts of the Scottish economy ............................................... 32 Fraser of Review of Scottish Business Surveys ........................................... 43 Scottish Labour Market ................................................................ 48 Allander Economic perspectives* Editorial Introduction ..................................................................... 55 Institute Fraser Economic Commentary – The complete catalogue of reviews, outlooks and articles: 1975 - 2015 Economic George Macgregor and Isobel Sheppard ................................... 57 Forty turbulent years: How the Fraser Economic Commentary recorded the evolution of the modern Commentary Scottish economy. Part 3 - The Nice decade turns nasty; banking Armageddon; and the politics of austerity, 2001 – 2015 Alf Young ................................................................................... 68 Scotland’s Productivity Performance – Latest data and insights Vol 39 No 2 Kenny Richmond and Jennifer Turnbull ..................................... 77 Scotland’s export performance: some recent evidence Jonathan Slow, Stewart Turner & Kenny Richmond ................. 91 International Value Chains: opportunities and challenges for small and developing countries Loe Franssen ........................................................................
    [Show full text]
  • Q+A with Andy Hornby
    Experiences of implementing SAP BW on HANA at Boots Experiences of implementing SAP BW on HANA at Boots UK 1 Phil Creek and Jamie Flaxman SAP centre of expertise Boots UK Experiences of implementing SAP BW on HANA at Boots UK 24 November 2014 No elements of this document may be reproduced in any form without the written permission of Alliance Boots. All trademarks and registered trademarks are the property of their respective owners. 2 Who we are… Phil Creek Jamie Flaxman Manager Business SAP Solution Analysis Architect MI & Loyalty 3 Alliance Boots • Presence in more than 27* countries • Over 120,000* employees • 4,600* health and beauty retail stores – of which just under 4,450* have a pharmacy • Operating more than 370* pharmaceutical wholesale distribution centres • Dispensing over 300* million items each year • In 2012, Alliance Boots announced that it had entered into a strategic partnership with Walgreen Co., the largest drugstore chain in the US • In August 2014, Alliance Boots and Walgreens communicated that they plan to merge in Q1 of the calendar year 2015. The new company will be named Walgreens Boots Alliance * Figures are approximations as at 31 March 2014, with the addition of Farmacias Ahumada data at the date of its acquisition on 11 August 2014, and include associates and joint ventures. 4 Health & Beauty – UK • 2,487* stores, 600* Boots Opticians practices, 430* Boots Hearingcare locations • 16* doctors’ surgeries located in store • 90%* of population within a 10 minute drive of a Boots store • Growing omni-channel
    [Show full text]
  • China Nepstar Chain Drugstore Ltd
    +44 20 8123 2220 [email protected] China Nepstar Chain Drugstore Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis https://marketpublishers.com/r/CCAE3DA5C6BBEN.html Date: September 2021 Pages: 50 Price: US$ 499.00 (Single User License) ID: CCAE3DA5C6BBEN Abstracts China Nepstar Chain Drugstore Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between China Nepstar Chain Drugstore Ltd. and its competitors. This provides our Clients with a clear understanding of China Nepstar Chain Drugstore Ltd. position in the Retail Industry. The report contains detailed information about China Nepstar Chain Drugstore Ltd. that gives an unrivalled in-depth knowledge about internal business- environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history. Another part of the report is a SWOT-analysis carried out for China Nepstar Chain Drugstore Ltd.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it. The China Nepstar Chain Drugstore Ltd. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios China Nepstar Chain Drugstore Ltd.
    [Show full text]
  • Fears for Share Schemes at Takeover Target Asda
    Vol 37 No 6 November 2020 Fears for share schemes at takeover target Asda More than 25,000 Asda employee shareholders fear From the chairman for the future of their successful SAYE-Sharesave schemes, based on the shares of parent company Many stories in this newspad show that - in Walmart, as a takeover loomed. Two billionaire addition to members’ core interest in share brothers from Blackburn appear to have won the schemes - much new thinking is bursting battle to buy Asda from US based Walmart, in a through at the same time. The Treasury may deal valuing the UK supermarket chain at £6.8bn. A become a shareholder in startups, people care consortium of Zuber and Mohsin Issa’s EG Group less who owns things as long as they deliver a and private equity firm TDR Capital will take a service, companies want to reward people who majority stake in Asda, unless a possible late contribute but aren’t necessarily employees. bidder, or the regulator, spoil the party. From the US we learn that grants of restricted The employee shareholders received a bumper £62m return from Walmart’s 2016 SAYE- stock or restricted stock units (RSUs) are now Sharesave, which matured in July last year. Its more common than grants of stock options. share price has more than doubled from $65 in Employees need to understand core issues with October 2015 to c. $146 (£113) by mid-October these grants if they are to build wealth and this year. prevent costly mistakes. Participating employees saved to accumulate share Users of myStockOptions.com in the United options in Walmart, with the standard 20 percent States are encouraged to start by looking at the discount, gaining the option of buying then selling stock grant agreement, the stock plan, and any them for a return after vesting.
    [Show full text]
  • HEALTH + Registered Offi Ce Helping People Look Alliance Boots Gmbh and Feel Their Best Baarerstrasse 94 CH-6300 Zug Switzerland
    Alliance Boots Boots Alliance Annual Report 2010/11 Annual For more information www.allianceboots.com HEALTH + Registered offi ce Helping people look Alliance Boots GmbH and feel their best Baarerstrasse 94 CH-6300 Zug Switzerland Contact [email protected] Alliance Boots Annual Report 2010/11 Overview Our performance in 2010/11 Glossary of key terms (for the year ended 31 March 2011) Constant currency Like for like revenue Trading profit Exchange rates applicable for the financial Like for like revenue on a constant currency basis Profit from operations before amortisation of information for the year ended 31 March 2010. compared to the comparable period in the customer relationships and brands, exceptional previous year. items and share of post tax earnings of EBITDA associates and joint ventures. Trading profit before underlying depreciation Net borrowings Revenue EBITDA Trading profit and amortisation. Cash and cash equivalents, restricted cash, Underlying depreciation and amortisation derivative financial instruments and borrowings Depreciation and amortisation adjusted to Exceptional items net of unamortised prepaid financing fees. exclude amortisation of customer relationships Items classified by Alliance Boots as exceptional and brands and depreciation and amortisation in nature. These are not regarded as forming Net finance costs within exceptional items. +15.1% +10 . 8 % +14 . 2 % part of the underlying trading activities of the Finance costs net of finance income. Group and so merit separate presentation to Underlying net finance costs allow stakeholders to understand the elements Restricted cash Net finance costs adjusted to exclude of financial performance and assess trends in Cash which is restricted for specific purposes exceptional items and timing differences within financial performance.
    [Show full text]
  • Annual Report 2017
    ANNUAL REPORT 2017 (Incorporated in Hong Kong with limited liability) (Stock Code : 00656) PROFIT ATTRIBUTABLE TO OWNERS OF THE PARENT RMB13,161.3 million Intelligence in Action 2017 marked the 25th anniversary of Fosun and our strongest financial year ever. Over these years, being a global company with Chinese roots, we are well-prepared for future opportunities with our strong industrial operations. We are dedicated to pursuing our strategy of “Centered around Family, Deeply Rooted in China, Innovating a Global Happiness Ecosystem”. We have hired some of the very best global talent to execute our customer-to-maker (C2M) strategy. We are fully confident that through Fosun’s core operations, innovative technologies and ONE Fosun ecosystem spanning over 35 million families, our C2M strategy will further advance and create value for our customers. In addition, through our newly launched Youle Customer Loyalty Program (“youlè”), Fosun aims at linking its products and services in our health, happiness and wealth ecosystems to create one-stop solutions for 1 billion families around the world. “A journey of a thousand miles begins with a single step”. In the past 25 years, Fosun has continued to be bold yet humble, building its success with stability and consistency. Looking ahead, we must continue to pursue our C2M strategy, focus on core operations, and develop our pioneering technology and innovation platform so we can become not just a global company with Chinese roots, but a global operator of world-class products and services. Furthermore, Fosun’s senior management and global partners* will step up their efforts to carry out more philanthropic works, with a view to doing more practical and effective initiatives to achieve our mission of helping our family customers live in a healthier, happier and wealthier life.
    [Show full text]
  • Sinopharm Group: 2H14 NDR Takeaways: Margin Expansion To
    Sinopharm Group | March 25, 2015 MORGAN STANLEY RESEARCH March 25, 2015 MORGAN STANLEY ASIA LIMITED+ Yolanda Hu Sinopharm Group [email protected] +852 2848-5649 Bin Li 2H14 NDR Takeaways: Margin Expansion [email protected] +852 2239-7596 Isabella Zhao to Continue [email protected] +852 2848-5887 Industry View Stock Rating Price Target Attractive Overweight HK$34.00 Sinopharm Group ( 1099.HK , 1099 HK ) China Healthcare / China Stock Rating Overweight Sinopharm’s solid sales growth and operating leverage are likely to Industry View Attractive continue in 2015, despite the uncertain policy outlook for the Price target HK$34.00 Up/downside to price target (%) 15 Healthcare industry. We find the stock attractive at 18x our revised Shr price, close (Mar 24, 2015) HK$29.50 2015e EPS. Reiterate OW. 52-Week Range HK$34.50-19.72 Sh out, dil, curr (mn) 2,568 Healthy 2015 sales outlook: Given decelerating GDP growth expected in Mkt cap, curr (mn) Rmb60,695 EV, curr (mn) Rmb78,243 2015, mgmt looks for growth of the end-user market to slow to 12%, and for Avg daily trading value (mn) HK$133 the distribution industry to grow 14-15%. Management remains confident about achieving its sales target of 3-5% above the market average. Fiscal Year Ending 12/14 12/15e 12/16e 12/17e ModelWare EPS (Rmb) 1.11 1.32 1.51 1.70 Margin improvement to continue in 2015, ... This is the first quarter that Prior ModelWare EPS 1.10 1.29 1.44 1.58 (Rmb) Sinopharm has recorded faster profit growth than sales growth, mainly due to: Consensus EPS (Rmb)§ 1.10 1.30 1.55 1.50 1) internal integration; 2) economies of scale; 3) optimizing customer mix Revenue, net (Rmb 200,131 235,469 272,701 313,245 (more direct sales to hospitals), and 4) more focus on the quality of growth.
    [Show full text]